Study number 780581
Dates
Jul 20 2026-Aug 12 2026
Group
C2
Location
Madison, Wisconsin
Age
24-60
Gender
Male and Female
Smokers Allowed
No
Compensation
$6,528
Referral
$350
This is a research study for an investigational drug being developed for the treatment of patients with heart failure with preserved ejection fraction, chronic kidney disease in type 2 diabetes mellitus, and atherosclerotic cardiovascular disease.
Madison, WI is currently recruiting Healthy Men and Women, age 24-60.
Refer a friend & receive $350 per qualified referral
Women Eligibility Criteria
Body Mass Index
Smoking criteria
Screening procedures
C2
Check-in: July 20
Check-out: July 30
Follow-up visit: Aug 12